Iohexol contrast medium induces QT prolongation in amiodarone patients

Br J Clin Pharmacol. 2004 Jul;58(1):96-8. doi: 10.1111/j.1365-2125.2004.02119.x.

Abstract

Aims: Amiodarone is widely used in ventricular tachyarrhythmias and atrial fibrillation, known to prolong QT-intervals. Concurrent administration of drugs prolonging QT- time can induce life-threatening ventricular tachyarrhythmia.

Methods: QT-interval changes following use of Iohexol contrast-medium for coronarangiography were observed comparing 21 patients taking long-term amiodarone therapy with 21 controls not taking amiodarone or QT-prolonging drugs retrospectively.

Results: Concurrent use of Iohexol and amiodarone was associated with significant prolongation of QTc-interval (433, 95%CI: 419-448 ms vs. 480, 95%CI: 422-483 ms, P < 0.001) the day after coronarangiograpgy. 6/21 patients showed severe prolonged QTc-interval of >500 ms.

Conclusion: Caution is advised until more is known about pro-arrhythmic effects of Iohexol.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Amiodarone / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Contrast Media / adverse effects*
  • Humans
  • Iohexol / adverse effects*
  • Long QT Syndrome / chemically induced*
  • Retrospective Studies
  • Tachycardia, Ventricular / drug therapy*

Substances

  • Anti-Arrhythmia Agents
  • Contrast Media
  • Iohexol
  • Amiodarone